Beam Therapeutics to Present Data Across Hematology Franchise, Including First Clinical Data for BEAM-101 in Sickle Cell Disease and ESCAPE Non-human Primate Data, at American Society of Hematology (A

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/9/2026

1. TTD
2. ABNB
3. NET
4. TEAM
5. FROG
6. DV
7. TWLO
8. CART
9. SPY
10. U

Go back to Beam Therapeutics to Present Data Across Hematology Franchise, Including First Clinical Data for BEAM-101 in Sickle Cell Disease and ESCAPE Non-human Primate Data, at American Society of Hematology (A
Beam Inc. (NASDAQ: BEAM) Delayed: 27.48 +0.23 (0.84%)
Previous Close $27.25    52 Week High $83.60 
Open $27.71    52 Week Low $82.96 
Day High $28.35    P/E 12.27 
Day Low $27.13    EPS $2.24 
Volume 1,324,259       

Beam Inc. (NASDAQ: BEAM) Delayed: 27.48 +0.23 (0.84%)
Previous Close $27.25    52 Week High $83.60 
Open $27.71    52 Week Low $82.96 
Day High $28.35    P/E 12.27 
Day Low $27.13    EPS $2.24 
Volume 1,324,259